Loading...
Loading...
Medical imaging (X-ray, CT, MRI), electronic health records, clinical trials, ECG/EEG, pathology
12,274 datasets
1,303 general practitioners in Henan Province, China, were surveyed in 2024 about their encounters with patients experiencing household energy insecurity. The data includes responses from providers across village clinics, township health centers, and county-, city-, and provincial-level hospitals. It was authored by Xiaoyu Liu and published under a CC-BY-4.0 license.
125 patients from the Lupus Italian REgistry (LIRE) initiating belimumab therapy were analyzed using Factor Analysis of Mixed Data (FAMD) and hierarchical clustering. The analysis identified four distinct clinical clusters based on 150 baseline variables, assessing disease activity and damage outcomes at 6 and 12 months. The dataset was authored by Mariele Gatto and last updated on 2026-05-28.
A serological study investigating antibodies against linear peptides of the phospholipase A2 receptor (PLA2R) in patients with membranous nephropathy. The dataset includes results from ELISA tests on 42 anti-PLA2R-negative patients and 32 anti-PLA2R-positive patients, measuring IgG reactivity to 123 synthesized peptides. The research was authored by Miao Wang and shared on figshare under a CC-BY-4.0 license.
61.9% of patients with PLA2R-associated membranous nephropathy who tested negative for conventional circulating anti-PLA2R antibodies reacted to at least one linear PLA2R peptide. The dataset contains ELISA measurements of IgG antibodies against 123 synthetic peptides from 42 biopsy-proven patients, authored by Miao Wang and last updated in May 2026. Three peptides—CysR-11, CTLD7-1, and CTLD7-2—showed the highest recognition frequencies and may serve as exploratory candidate biomarkers.
8.1 million inpatient cases with diabetes were analyzed from German national DRG statistics covering 2021-2023. The dataset compares mortality rates and length of stay between 300 diabetes-certified hospitals and 1,103 non-certified hospitals. It was authored by Marie Auzanneau and shared under a CC-BY-4.0 license.
A 3.4 MB PDF case report authored by Ana Filipa Bolas, published on figshare under a CC-BY-4.0 license and last updated in May 2026. It details the management of a 33-year-old woman with glucokinase-related monogenic diabetes (GCK-MODY) during her pregnancy, including the use of continuous glucose monitoring and intensive insulin therapy.
From August 2016 to November 2024, 133 children with acute pancytopenia were enrolled at the Children’s Hospital of Chongqing Medical University. The dataset, created by Junya Ma, compares thoracic and abdominal computed tomography features across three hematologic malignancies: malignancy-associated hemophagocytic lymphohistiocytosis, acute leukemia, and Epstein–Barr virus-associated HLH.
Katarzyna Garbacz's study analyzes 165 Staphylococcus aureus isolates from 82 pediatric cystic fibrosis patients over a three-year period. The dataset includes results from molecular typing (spa and SCCmec) and antimicrobial susceptibility testing. It was last updated on 2026-05-28 and is shared under a CC-BY-4.0 license.
Twenty-three meta-analyses and systematic reviews were included in an umbrella review assessing the efficacy and safety of GLP-1 receptor agonists for Metabolic dysfunction-associated steatotic liver disease (MASLD). The review, authored by Hui Wu and last updated in May 2026, summarizes outcomes into five categories: liver characteristics, enzyme levels, anthropometric measurements, metabolic markers, and inflammatory markers. It is shared under a CC-BY-4.0 license as an 8.7 MB DOCX file on figshare.
Supplementary file 2_Efficacy and safety of GLP-1 receptor agonists in patients with metabolic-associated fatty liver diseases: an umbrella review.xlsx contains summarized findings from a review of 23 meta-analyses and systematic reviews. The dataset, authored by Hui Wu and last updated on 2026-05-28, aggregates evidence on GLP-1 RAs for MASLD across five outcome categories: liver characteristics, liver enzyme levels, anthropometric measurements, metabolic markers, and inflammatory markers. The review was conducted following PRISMA 2020 guidance, searching five databases from inception to 30 September 2025.
A retrospective cohort of 185 patients with pulmonary metastases treated with stereotactic body radiotherapy (SBRT). Nutritional status was assessed using four tools—Nutritional Risk Index (NRI), Controlling Nutritional Status (CONUT), Nutritional Risk Screening 2002 (NRS), and Prognostic Nutritional Index (PNI)—to evaluate their prognostic utility for overall survival. The dataset was created by Yunjie Zhang and last updated on 2026-05-28.
A 2026 review document aggregates findings from 37 studies on human seroprevalence and 24 studies on wild rodent prevalence of Schistosoma japonicum in China, covering literature from 2015 onward. The author, Fen Chen, compiled data from over 46 million human serum samples and 14,381 wild rodents. The work discusses diagnostic methods and epidemiological features to inform control strategies.
A review document provides an update on diagnostic technologies and epidemiological features of Schistosoma japonicum in China from 2015 onward. It aggregates data from 37 studies involving 46,910,186 human serum samples and 24 studies covering 14,381 wild rodents. The document was authored by Fen Chen and last updated on 2026-05-28.
A clinical study dataset of 164 patients with resectable non-small cell lung cancer (stages IB-IIIB) who received neoadjuvant chemoimmunotherapy followed by surgery. The data compares recurrence-free survival, overall survival, and adverse events between patients who completed the full perioperative regimen (n=37) and those who did not (n=127). The dataset was authored by Zhoujunyi Tian and last updated on 2026-05-28.
Zhoujunyi Tian's research dataset compares outcomes for patients with resectable non-small cell lung cancer who completed versus did not complete a full perioperative chemoimmunotherapy regimen. The dataset includes 164 patients (37 completed, 127 non-completed) and analyzes recurrence-free survival, overall survival, and adverse events. It was last updated on 2026-05-28 and is shared under a CC-BY-4.0 license.
Zhoujunyi Tian's dataset compares recurrence-free survival, overall survival, and adverse event rates between patients who completed a full perioperative chemoimmunotherapy regimen and those who did not. It includes data from 164 patients with resectable non-small cell lung cancer at clinical stage IB-IIIB. The dataset was last updated on 2026-05-28.
A 14.7 KB document analyzes 164 patients with resectable non-small cell lung cancer to compare outcomes between those who completed a full perioperative chemoimmunotherapy regimen and those who did not. Authored by Zhoujunyi Tian and shared on figshare in May 2026, the study found no significant survival benefit from protocol completion but noted a higher incidence of any-grade adverse events. The analysis used Inverse Probability of Treatment Weighting to adjust for baseline characteristics.
A clinical study by Zhoujunyi Tian, last updated in May 2026, compares outcomes for patients with resectable non-small cell lung cancer who did or did not complete a full perioperative chemoimmunotherapy regimen. The dataset includes 164 patients divided into a completed group (n=37) and a non-completed group (n=127), with analyses of recurrence-free survival, overall survival, and adverse events.
Raffaella Moretti's 2026 study on figshare assesses the feasibility and contribution of polymyography for diagnosing hyperkinetic movement disorders in children. The research retrospectively reviewed clinical and neurophysiological data from 60 consecutive patients over a two-year period, with 56 included in the final analysis. The study found polymyography significantly improved diagnostic accuracy, particularly for distinguishing tremor from myoclonus.
A retrospective cross-sectional study from Pu’er City Hospital of Traditional Chinese Medicine compared 3,036 hypertensive adults across two periods: pre-pandemic (January 2017–December 2019) and post-pandemic (January 2023–March 2025). The dataset, authored by Jin Yuan and shared under a CC-BY-4.0 license, includes serum uric acid levels and cardiorenal complication prevalence to assess pandemic-related changes and interaction effects.